BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1015 related articles for article (PubMed ID: 29743203)

  • 21. Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammation.
    Yuan Y; Li H; Sreeram K; Malankhanova T; Boddu R; Strader S; Chang A; Bryant N; Yacoubian TA; Standaert DG; Erb M; Moore DJ; Sanders LH; Lutz MW; Velmeshev D; West AB
    Mol Neurodegener; 2024 Jun; 19(1):47. PubMed ID: 38862989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers.
    Zhao Y; Perera G; Takahashi-Fujigasaki J; Mash DC; Vonsattel JPG; Uchino A; Hasegawa K; Jeremy Nichols R; Holton JL; Murayama S; Dzamko N; Halliday GM
    Brain; 2018 Feb; 141(2):486-495. PubMed ID: 29253086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired neurogenesis in the hippocampus of an adult VPS35 mutant mouse model of Parkinson's disease through interaction with APP.
    Jiang M; Tu HT; Zhang K; Zhang W; Yu WP; Xu J; Tan EK; Guo KH; Zeng L
    Neurobiol Dis; 2021 Jun; 153():105313. PubMed ID: 33636388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenic LRRK2 regulates ciliation probability upstream of tau tubulin kinase 2 via Rab10 and RILPL1 proteins.
    Sobu Y; Wawro PS; Dhekne HS; Yeshaw WM; Pfeffer SR
    Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33653948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular effects mediated by pathogenic LRRK2: homing in on Rab-mediated processes.
    Madero-Pérez J; Fdez E; Fernández B; Lara Ordóñez AJ; Blanca Ramírez M; Romo Lozano M; Rivero-Ríos P; Hilfiker S
    Biochem Soc Trans; 2017 Feb; 45(1):147-154. PubMed ID: 28202668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LRRK2 and Rab GTPases.
    Pfeffer SR
    Biochem Soc Trans; 2018 Dec; 46(6):1707-1712. PubMed ID: 30467121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson's VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B.
    Pal P; Taylor M; Lam PY; Tonelli F; Hecht CA; Lis P; Nirujogi RS; Phung TK; Yeshaw WM; Jaimon E; Fasimoye R; Dickie EA; Wightman M; Macartney T; Pfeffer SR; Alessi DR
    Sci Adv; 2023 Dec; 9(50):eadj1205. PubMed ID: 38091401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration.
    Jeong GR; Jang EH; Bae JR; Jun S; Kang HC; Park CH; Shin JH; Yamamoto Y; Tanaka-Yamamoto K; Dawson VL; Dawson TM; Hur EM; Lee BD
    Mol Neurodegener; 2018 Feb; 13(1):8. PubMed ID: 29439717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A.
    Rivero-Ríos P; Romo-Lozano M; Madero-Pérez J; Thomas AP; Biosa A; Greggio E; Hilfiker S
    J Biol Chem; 2019 Mar; 294(13):4738-4758. PubMed ID: 30709905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous Rab38 regulates LRRK2's membrane recruitment and substrate Rab phosphorylation in melanocytes.
    Unapanta A; Shavarebi F; Porath J; Shen Y; Balen C; Nguyen A; Tseng J; Leong WS; Liu M; Lis P; Di Pietro SM; Hiniker A
    J Biol Chem; 2023 Oct; 299(10):105192. PubMed ID: 37625589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Divergent Effects of G2019S and R1441C LRRK2 Mutations on LRRK2 and Rab10 Phosphorylations in Mouse Tissues.
    Iannotta L; Biosa A; Kluss JH; Tombesi G; Kaganovich A; Cogo S; Plotegher N; Civiero L; Lobbestael E; Baekelandt V; Cookson MR; Greggio E
    Cells; 2020 Oct; 9(11):. PubMed ID: 33105882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The LRRK2 kinase substrates RAB8a and RAB10 contribute complementary but distinct disease-relevant phenotypes in human neurons.
    Mamais A; Sanyal A; Fajfer A; Zykoski CG; Guldin M; Riley-DiPaolo A; Subrahmanian N; Gibbs W; Lin S; LaVoie MJ
    Stem Cell Reports; 2024 Feb; 19(2):163-173. PubMed ID: 38307024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation.
    Fan Y; Tonelli F; Padmanabhan S; Baptista MAS; Riley L; Smith D; Marras C; Howden A; Alessi DR; Sammler E
    J Vis Exp; 2020 Mar; (157):. PubMed ID: 32250352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic background influences LRRK2-mediated Rab phosphorylation in the rat brain.
    Kelly K; Chang A; Hastings L; Abdelmotilib H; West AB
    Brain Res; 2021 May; 1759():147372. PubMed ID: 33600829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinase activity of mutant LRRK2 manifests differently in hetero-dimeric vs. homo-dimeric complexes.
    Leandrou E; Markidi E; Memou A; Melachroinou K; Greggio E; Rideout HJ
    Biochem J; 2019 Feb; 476(3):559-579. PubMed ID: 30670570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pathway for Parkinson's Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain.
    Dhekne HS; Yanatori I; Gomez RC; Tonelli F; Diez F; Schüle B; Steger M; Alessi DR; Pfeffer SR
    Elife; 2018 Nov; 7():. PubMed ID: 30398148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vps35 in cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in Drosophila.
    Inoshita T; Arano T; Hosaka Y; Meng H; Umezaki Y; Kosugi S; Morimoto T; Koike M; Chang HY; Imai Y; Hattori N
    Hum Mol Genet; 2017 Aug; 26(15):2933-2948. PubMed ID: 28482024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation.
    Madero-Pérez J; Fdez E; Fernández B; Lara Ordóñez AJ; Blanca Ramírez M; Gómez-Suaga P; Waschbüsch D; Lobbestael E; Baekelandt V; Nairn AC; Ruiz-Martínez J; Aiastui A; López de Munain A; Lis P; Comptdaer T; Taymans JM; Chartier-Harlin MC; Beilina A; Gonnelli A; Cookson MR; Greggio E; Hilfiker S
    Mol Neurodegener; 2018 Jan; 13(1):3. PubMed ID: 29357897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Wauters F; Cornelissen T; Imberechts D; Martin S; Koentjoro B; Sue C; Vangheluwe P; Vandenberghe W
    Autophagy; 2020 Feb; 16(2):203-222. PubMed ID: 30945962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.